669 related articles for article (PubMed ID: 30798811)
1. Hepcidin-ferroportin axis in health and disease.
Ginzburg YZ
Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin and its multiple partners: Complex regulation of iron metabolism in health and disease.
Ginzburg YZ
Vitam Horm; 2023; 123():249-284. PubMed ID: 37717987
[TBL] [Abstract][Full Text] [Related]
3. Regulators of hepcidin expression.
Roth MP; Meynard D; Coppin H
Vitam Horm; 2019; 110():101-129. PubMed ID: 30798807
[TBL] [Abstract][Full Text] [Related]
4. Modulation of hepcidin to treat iron deregulation: potential clinical applications.
Blanchette NL; Manz DH; Torti FM; Torti SV
Expert Rev Hematol; 2016; 9(2):169-86. PubMed ID: 26669208
[TBL] [Abstract][Full Text] [Related]
5. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
Wallace DF; McDonald CJ; Ostini L; Iser D; Tuckfield A; Subramaniam VN
Am J Hematol; 2017 Oct; 92(10):1052-1061. PubMed ID: 28681497
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
[TBL] [Abstract][Full Text] [Related]
7. Current status of iron metabolism: Clinical and therapeutic implications.
Conde Diez S; de Las Cuevas Allende R; Conde García E
Med Clin (Barc); 2017 Mar; 148(5):218-224. PubMed ID: 28073521
[TBL] [Abstract][Full Text] [Related]
8. Iron and hepcidin: a story of recycling and balance.
Camaschella C
Hematology Am Soc Hematol Educ Program; 2013; 2013():1-8. PubMed ID: 24319154
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
Nemeth E; Ganz T
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
[TBL] [Abstract][Full Text] [Related]
10. Update on iron metabolism and molecular perspective of common genetic and acquired disorder, hemochromatosis.
Yun S; Vincelette ND
Crit Rev Oncol Hematol; 2015 Jul; 95(1):12-25. PubMed ID: 25737209
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin and disorders of iron metabolism.
Ganz T; Nemeth E
Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screening of small molecules identifies hepcidin antagonists.
Fung E; Sugianto P; Hsu J; Damoiseaux R; Ganz T; Nemeth E
Mol Pharmacol; 2013 Mar; 83(3):681-90. PubMed ID: 23292796
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin: regulation of the master iron regulator.
Rishi G; Wallace DF; Subramaniam VN
Biosci Rep; 2015 Mar; 35(3):. PubMed ID: 26182354
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin and iron disorders: new biology and clinical approaches.
Arezes J; Nemeth E
Int J Lab Hematol; 2015 May; 37 Suppl 1():92-8. PubMed ID: 25976966
[TBL] [Abstract][Full Text] [Related]
16. Systemic iron homeostasis and erythropoiesis.
Papanikolaou G; Pantopoulos K
IUBMB Life; 2017 Jun; 69(6):399-413. PubMed ID: 28387022
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of iron overload disorders and iron-linked anemias.
Kaplan J; Ward DM; De Domenico I
Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258
[TBL] [Abstract][Full Text] [Related]
18. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin and ferroportin: the new players in iron metabolism.
De Domenico I; Ward DM; Kaplan J
Semin Liver Dis; 2011 Aug; 31(3):272-9. PubMed ID: 21901657
[TBL] [Abstract][Full Text] [Related]
20. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E
Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
